The cystine -cystine (CC) chemokine monocyte chemoattractant protein-1 (MCP-1) has been established playing a pathogenic role in the development of atherosclerosis due to its chemotactic ability of leading monocytes to locate to subendothelia. Recent studies have revealed more MCP-1 functions other than chemotaxis. Here we reported that various concentrations (0.1 -100 ng/ml) of MCP-1 induced human umbilical vein endothelial cell (HUVEC) strain CRL-1730 apoptosis, caspase-9 activation, and a couple of mitochondrial alterations. Moreover, MCP-1 upregulated p53 expression of HUVECs and the p53-specific inhibitor pifithrin-a (PFTa) rescued the MCP-1-induced apoptosis of HUVECs. Furthermore, PKC ( protein kinase C) activation or inhibition might also affect HUVECs apoptosis induced by MCP-1. These findings together demonstrate that MCP-1 exerts direct proapoptotic effects on HUVECs in vitro via a p53-dependent mitochondrial pathway.
Introduction
Chemokines or chemotactic cytokines are a group of small (8) (9) (10) (11) proteins that recruit circulating leukocytes to sites of inflammation or injury. Based on whether or not amino acid(s) inserted between the first two cysteine residues at N-terminal, chemokines were divided into the four subfamilies, CXC, CC, CX3C, and C [1] . They were considered mainly chemotactic, but recent studies revealed the versatilities of chemokines [2] .
Monocyte chemoattractant protein-1 (MCP-1, CCL2) is the first identified CC subfamily member that can be secreted by many immune or non-immune cell types, including monocyte, endothelial cell (EC), smooth muscle cell, fibroblast, etc. MCP-1 plays a vital role in atherosclerosis by directing monocytes to permeate into the subendothelia where they become foam cells, and form fatty streak and finally atherosclerotic plaque [3] . Either MCP-1 or its receptor CCR2 deficiency reduced susceptibility to atherosclerosis [4, 5] . Anti-atherosclerosis drugs might also work via MCP-1 repression in human ECs [6] .
EC from all blood vessels maintained their anticoagulant properties [7] , thus ECs apoptosis might lead to the pathogenesis of atherosclerosis [8] . Apoptotic ECs have been found in atherosclerotic lesions of both animal models and human patients. ECs in the lesions regenerated faster, showed increased pro-apoptotic proteins and decreased anti-apoptotic proteins [9] . Most atherosclerogenic risk factors were reported to evoke ECs apoptosis in vitro or increase circulating ECs in vivo [8] , thereby disturbing vascular homeostasis, and increasing smooth muscle cell(s) proliferation, migration, and blood coagulation, which act as initiating events in atherogenesis [7, 10] . It has been reported that in vivo local shear stress patterns or hyperglycemia influenced luminal EC apoptosis [11, 12] , and these factors determined atherosclerotic vulnerability and lesion size [13, 14] . Therefore, the close relationship between ECs apoptosis and atherosclerosis has been acknowledged.
We have found that MCP-1 induced human umbilical endothelial vein cell (HUVEC) apoptosis characterized by cell proliferation inhibition, G 0 /G 1 arrest, DNA fragmentation [15] , upregulation of proapoptotic proteins Bax and Fas while downregulation of antiapoptotic protein Bcl-2 [16] . AnnexinV/FITC-propidium iodide (PI) staining also confirmed MCP-1 induced HUVEC apoptosis in which CCR2 was involved. It was found that MCP-1 induced CCR2 expression; either CCR2 antisense oligodeoxynucleotide or its antagonist inhibited MCP-1-induced HUVEC apoptosis in vitro [17] . These results indicated that MCP-1 not only promoted foam cell formation, but also induced EC apoptosis. However, the elaborate mechanisms of MCP-1-induced ECs apoptosis largely remain to be elucidated. In this paper, we reported the mechanisms of HUVECs apoptosis induced by MCP-1, through which we can better understand MCP-1 functions in ECs other than chemotaxis and which will also enrich our knowledge about the relationship between chemokines and apoptosis.
Materials and Methods
Cell culture and growth curve HUVEC strain CRL-1730 (ATCC) was cultured in complete DMEM/F12 culture medium (containing 20% FBS). HUVEC-specific marker von Willebrand factor (vWF) was detected with rabbit antibody (1:80 dilution; ZhongShan Golden Bridge, Beijing, China) by immunofluorescence.
Cultured cells were digested with 0.025% trypsin when grown into confluence, suspended with complete DMEM/ F12 medium, stained with 0.04% trypan blue, and counted. Equivalent cells were inoculated in 24-well plates and cultured; cells in 3 wells were counted every 24 h for 8 days, then the cell growth curve was plotted.
MTT assay
Confluent cultured cells were digested with 0.025% trypsin and suspended with complete DMEM/F12 medium. Cells were counted and inoculated in 96-well plates at a density of 5Â10 3 cells per well and cultured. After serum starvation with 1% FBS medium, synchronized cells were treated with MCP-1 (PeproTech, Rocky Hill, USA) at various concentrations (0.1-100 ng/ml) and further cultured for 48 h. Then, 20 ml MTT (5 mg/ml; SigmaAldrich, St Louis, USA) was added into each well and the resulting mixture was incubated for additional 4 h when violet crystals emerge. Supernatant was pipetted out and 100 ml DMSO was added into each well. The plates were oscillated for 10 min and scanned at 490 nm under a microplate reader (HumaReader, Human, Egypt).
Annexin V-FITC/PI double-staining flow cytometry Synchronized cells were treated with MCP-1 and cultured for 48 h. Digested cells were collected by centrifugation at 1500 rpm for 5 min, washed with pre-cooled PBS (2000 rpm, 5 min) twice and resuspended with 250 ml binding buffer of Annexin V-FITC Apoptosis Detection Kit (KeyGEN Biotech, Nanjing, China). A total of 100 ml cell suspension was incubated with 5 ml Annexin V-FITC and 10 ml of 20 mg/ml PI for 30 min in the dark at room temperature and detected with a flowcytometer (Beckman Coulter, Fullerton, USA).
Detection of caspase-9 activity Caspase-9 activity was measured using the caspase-9 assay kit (Beyotime, Haimen City, Jiangdu Province, China) with N-acetyl -Leu-Glu-His-Asp-P-nitroanilide (Ac-LEHDpNA) as the colorimetric substrate as stated elsewhere [18] . Cultured HUVECs treated with various concentrations of MCP-1 for 48 h were washed, digested, and collected.
A total of 100 ml cell lysates was obtained from 2 Â 10 6 cells, incubated for 15 min on ice, then centrifuged at 16000 g for 10 min at 48C. Protein concentration of the supernatants was measured with Bradford assay kit (Beyotime) and adjusted to 1-3 mg/ml. Each 10 ml supernatant was mixed with 10 ml Ac-LEHD-pNA (2 mM) in assay buffer. The 100 ml reaction mixture was incubated at 378C for 2 h until absorbance at 405 nm was determined. The experiment was repeated three times and caspase-9 activity was expressed as fold(s) change over control (without colorimetric substrate) once corrected for baseline with pNA (10 mM).
Measurement of mitochondrial membrane potential (Dc m ) MCP-1 pre-treated cells were incubated with 10 mg/ml fluorescent probe Rhodamine123 (Molecular Probes, Eugene, USA) at 378C for 30 min as previously described [19] with minor modification. Cells were then washed in pre-cooled PBS (2000 rpm, 5 min) twice, and analyzed by flow cytometry with excitation wavelength 470-490 nm and emission wavelength 515-565 nm.
Determination of mitochondrial mass
Cultured HUVECs treated with various concentrations of MCP-1 were synchronized and collected as stated above. Mitochondrial mass was detected with NAO (10-N-nonyl acridine orange) staining cytometry [20] . Briefly, cells (1Â10 6 ) were incubated with 100 nM NAO (Biotium, Hayward, USA) at 378C in the dark for 15 min, and analyzed on a flow cytometer (FACS Calibur; Becton Dickinson, Mountain View, USA) with maximum absorbing wavelength of 519 nm and excitation wavelength of 495 nm.
Analysis of cytochrome c release HUVECs were cultured, treated with various concentrations of MCP-1 for 48 h, synchronized and collected as stated above. Cells were suspended with PBS supplemented with 0.05% Triton-X 100 for 1 min, and washed with pre-cooled PBS twice; then blocked with goat serum (1:250 dilution; Boster BioTech., Wuhan, China) for 10 min. Mouse antihuman cytochrome c (cyt c) antibody (1:200 dilution; Santa Cruz Biotechnology, Santa Cruz, USA) was added and incubated at 48C overnight. Cells were washed with pre-cooled PBS twice and treated with FITC-labeled goat anti-mouse IgG (1:200 dilution; ZhongShan Golden Bridge) at 378C for 1 h. After washed with PBS, the cells were analyzed with flow cytometry.
Detection of intracellular calcium concentration [Ca

21
] i Intracellular Ca 2þ concentration ([Ca 2þ ] i ) of HUVECs was measured by monitoring the fluorescence emission of Fura 2 using a spectrofluorophotometer (RF-1501; Shimadzu, Kyoto, Japan) [21] . Cells were serum starved and synchronized, treated with various concentrations of MCP-1 (0.1-100 ng/ml) and 5 mM Fluo-3/AM. The mock control was treated only with 5 mM Fluo-3/AM. After 48 h of incubation, the flasks were gently oscillated for 45 min at 378C and sit in room temperature for 15 min. Cells were then washed three times, centrifuged at 900 rpm for 5 min to exclude remaining Fura-2/AM outside membrane. Resuspended with Hanks buffer containing 0.2% BSA, HUVECs (2Â10 6 /ml) were transferred to quartz vials and detected by measuring 500 nm emission at 340/380 nm excitation. The cells were mingled with Hanks buffer containing 10% TritonX-100 to destruct the membranes (R max ), followed by perfusion with nominally Ca 2þ -free Hanks buffer plus 500 mM EGTA to chelate Ca 2þ (R min ). The fluorescent emission was corrected for autofluorescence, and the 340/380 intensity ratio (R values) was recorded. [Ca 2þ ] i values were calculated using the formula:
The kDa value was taken as 224 nM.
Quantitative real-time reverse transcriptase-polymerase chain reaction HUVECs were pre-treated with MCP-1 for 48 h, synchronized and washed with PBS. Total RNA from 10 cm 2 flasks was extracted with 1 ml RNAiso TM plus reagent (TaKaRa, Osaka, Japan) according to the manufacturer's instructions. RNA concentration and integrity were determined with NanoDrop spectrophotometer and agarose gel electrophoresis.
Totally, 650 ng RNA was reverse transcribed into firststrand cDNA using PrimeScript RT reagent Kit (TaKaRa) in 20 ml reaction. Reverse transcription was performed as follows: 378C for 15 min and 858C for 5 s on Mastercycler (Eppendorf, Hamburg, Germany).
Then, 3 ml cDNA preparation was diluted to a final polymerase chain reaction (PCR) volume of 15 ml containing 7.5 ml SYBR Premix Ex Tag TM II and 0.5 ml primers, and amplified with SYBR w PrimeScript w RT-PCR Kit II (TaKaRa) according to the manufacturer's instructions. PCR primers were: p53 forward 5 0 -ACCACCATC CACTACAACTACAT-3 0 , p53 reverse 5 0 -CAGGACAGG CACAAACACG-3 0 , Actin forward 5 0 -CCAGCCTTCCT TCTTGGGTAT-3 0 and Actin reverse 5 0 -TTGGCATAGAG GTCTTTACGG-3 0 . Real-time PCR was performed under the following conditions: 958C for 150 s; 40 cycles of 958C for 10 s, 54.98C for 20 s using Bio-Rad iCycler. The p53 expression efficiency is calculated from the Ct values relative to that of Actin.
Western blot analysis
Cell lysates and supernatants of MCP-1 pre-treated or untreated HUVECs were obtained and the protein concentrations were determined as stated above. Protein samples (50 mg) were heated and then separated by 10% sodium dodecyl sulfate -polyacrylamide gel electrophoresis (SDS-PAGE). The proteins were transferred onto polyvinylidene fluoride membranes (Millipore, Bedford, USA), which were incubated with corresponding primary antibodies at 48C overnight. The monoclonal antibodies against p53 and caspase-9 (1:200 dilution; Santa Cruz Biotechnology) were used, with b-actin (1:200 dilution; Beyotime) as an internal control. Washed membranes were incubated for 60 min with HRP-labeled goat anti-mouse IgG (Jackson ImmunoResearch, West Grove, USA). Membranes were washed again and subject to the BeyoECL Plus chemiluminescent kit (Beyotime) for chemiluminescence detection and then exposed to X-ray films.
Statistical analysis
Data analysis was performed using SPSS statistics software. Statistical significance was determined using the Student's two-tailed t-test. P , 0.05 was regarded as significant. All experiments were performed at least three times and the data were shown as mean + SD.
Results
MCP-1-induced HUVECs apoptosis
HUVEC line CRL-1730 (ATCC) was cultured for 3-5 days until grown confluent. As shown under microscope, the majority of cells exhibited uniform and 'cobble stone' morphology [ Fig. 1(A) ]. Immunostaining the cells for EC specific marker vWF further confirmed that all cells were positive to anti-vWF antibody [ Fig. 1(B) ].
To analyze the effect of MCP-1 on HUVEC viability, MTT reduction assay was used to dye cultured HUVECs that were pre-treated with various concentrations of MCP-1 (0.1-100 ng/ml) for 48 h. Fig. 1(C) indicated that MCP-1 inhibited HUVECs proliferation dose dependently.
We further explored whether apoptosis took place in HUVECs when stimulated with MCP-1. MCP-1 pre-treated HUVECs were analyzed with PI-and FITC-labeled Annexin V double-staining flow cytometry. Annexin V bound specifically to phosphatidylserine (PS) exposed inside-out on the membrane, an early-phase apoptotic signal. Simultaneously, the dye PI was unable to pass through integrate cell membrane during the initial stages of apoptosis. MCP-1 increased early apoptotic HUVECs (FITC þ /PI 2 ) rate as compared with untreated control [ Fig. 1(D) ].
MCP-1 upregulated caspase-9 activity and expression Caspase-9 is an important downstream molecule in the major apoptotic pathways. As shown in Fig. 2(A) , caspase-9 activity increased dose dependently with MCP-1 as indicated by OD 405 absorption with Ac-LEHD-pNA as the colorimetric substrate. Meanwhile, caspase-9 expression of HUVECs was also upregulated by MCP-1 treatment in a similar trend [ Fig. 2(B) ] as detected by western blot. These findings demonstrate that MCP-1-induced caspase-9 activity at least partially is due to the increase of its protein expression.
Mitochondria were involved in MCP-1-induced HUVECs apoptosis Caspase-9 is mainly considered as a mitochondrial apoptotic pathway involved signal. We thus turned our attention to mitochondrial perturbations of HUVECs after MCP-1 treatment.
The membrane-permeable cationic fluorescent dye Rh123 was used to determine the mitochondrial membrane potential of living cells. As to the same cell type, the volumes of mitochondria varied little; Rh123 fluorescence was proportionate almost exclusively to the absolute amount of the dye accumulated in mitochondria, hence the potential across mitochondrial membrane (DC). MCP-1 dose dependently reduced HUVECs mitochondrial membrane potential as implicated by decreased fluorescence detected by flow cytometry [ Fig. 3(A) ].
Next, we sought to determine mitochondrial mass. NAO (10-N-nonyl acridine orange) is a derivative of acridine orange, specifically binds to the negatively charged phospholipid cardiolipin on the inner membrane of mitochondria independent of the mitochondrial energy state. It is thus an appropriate marker of the mitochondrial membrane surface per unit of cell mass. After being stimulated with MCP-1 for 48 h, HUVECs mitochondrial mass decreased dose dependently [ Fig. 3(B) ].
An important event in mitochondrial apoptotic pathway is cyt c release. As shown in Fig. 3(C) , mitochondrial cyt c fluorescence decreased and meanwhile cytoplasmic cyt c fluorescence increased, indicating that MCP-1 treatment promoted HUVECs cyt c release.
p53 played an important role in MCP-1-induced HUVECs apoptosis Since p53 transcription either dependently or independently activates genes in both extrinsic and intrinsic apoptotic pathways, we examined p53 expression of HUVECs treated with MCP-1 for 48 h. The mRNA level of p53 was quantified by real-time PCR, and all samples were exactly amplified as indicated by amplification curves and melting curves (not shown). MCP-1 raised p53 mRNA level of HUVECs [ Fig. 4(A) ]. Western blot also confirmed that MCP-1 enhanced p53 expression [ Fig. 4(B) ].
HUVECs pre-treated with MCP-1 (10 ng/ml) were preincubated with the various concentrations of the p53-selective inhibitor pifithrin-a (PFTa) for 30 min. As revealed by Annexin V-FITC/PI double-staining flow cytometry, 30 mM PFTa rescued EC apoptosis induced by MCP-1 [ Fig. 4(C) ].
Protein kinase C modulated MCP-1-induced HUVECs apoptosis We investigated whether or not intracellular calcium perturbations happened during MCP-1-induced HUVECs apoptosis using the fluorescent indicator Fura-2 acetoxymethyl 
Discussion
Atherosclerosis is a serious chronic cardiovascular disease that is influencing a large portion of the modern population. Chemokine MCP-1 is an assured risk factor [4, 5] . Besides its conventional role of chemotaxis and proinflamation, we found that it was proapoptotic to HUVEC, which might be a new view for the roles of MCP-1 in the initiation and development of atherosclerosis. We believe that MCP-1 exerts far more complicated functions in atherosclerosis than our current knowledge. So, we investigated the mechanisms of this new function of MCP-1 to HUVEC.
At first, we verified MCP-1 induced HUVECs apoptosis in vitro by cytometry, and detected elevated caspase-9 expression and activity. It was reported that plasma MCP-1 level ranged from 0.1-0.4 ng/ml in patients of cardiovascular diseases [22, 23] . An in vitro study also revealed that MCP-1 manifested monocytic chemoattractant activity at very low concentration and reached highest at 100 ng/ml [24] . To mimic the micro-environment that HUVEC experience in vivo, MCP-1 concentrations used in this study precisely cover its chemotactic and atherogenic ability.
Next, we checked whether the mitochondrial pathway was involved in apoptosis. The results showed that the structural and functional integrity of HUVECs mitochondria was challenged by MCP-1 treatment, including membrane potential and mitochondria mass decrease, cyt c release, etc. The roles of mitochondria in apoptosis are complex. Various proapoptotic stimuli were directly responsible for mitochondrial apoptotic events, including loss of mitochondrial transmembrane potential, release of cyt c or other apoptosis activators normally residing in the intermembrane space of mitochondria [25] . The mitochondrial masses reduced due to the destabilization process. The released molecules translocated to cytosol and/or nucleus, activated caspases, or hindered the actions of cytosolic antiapoptotic proteins [26] . The interactions between pro-and anti-apoptotic proteins and downstream effects led to cell cycle arrest and finally apoptosis.
In addition, the present study revealed the role of p53 in MCP-1-induced HUVECs apoptosis. p53 was upregulated by MCP-1 and the p53-specific inhibitor PFTa rescued the MCP-1-affected HUVECs apoptosis. p53-induced apoptosis was reported to be regulated by target gene transcription dependent and independent signaling pathways [27, 28] . Mihara et al. reported that the p53 protein directly bound to the protective BclXL via its DNA binding domain and the Bcl2 proteins, unveiling the key to the mechanism of stress-induced apoptosis.
The p53-BclXL-Bcl2 complexes induced permeabilization of the outer mitochondrial membrane, resulting in cyt c release [29] . PFTa is a reversible inhibitor of p53-mediated apoptosis and p53-dependent gene transcription. It has been reported that 30 mM PFTa prevents doxorubicin-induced HUVEC apoptosis [30] , which is similar to the results of our study. PKC has been demonstrated both pro-apoptotic and antiapoptotic in different cell types [31] . Ca 2þ or diacylglycerol (DAG) binding might cause PKC conformational changes and increase its hydrophobicity, which facilitates its translocation and binding to plasma membrane [32] . Since PKC activation is Ca 2þ dependent, we examined intracellular calcium concentration and found it was raised after MCP-1 treatment. The PKC activator PMA enhanced MCP-1-induced HUVECs apoptosis, which was attenuated by PKC inhibitor chelerythrine. As proved by other studies, MCP-1-induced HUVECs apoptosis was enhanced by 100 nM PKC activator PMA [33, 34] , but was impeded by 1 nM PKC inhibitor chelerythrine [35] [36] [37] . A previous study demonstrated that the IC 50 value of chelerythrine to PKC is 0.7 mM [38] . While the concentrations we used rendered only partial inhibition of PKC, the early apoptosis induced by MCP-1 was partially rescued, and there might be an optimal concentration that worked nicely. Thus, PKC may also modulate MCP-1 induced HUVECs apoptosis.
The peripheral blood MCP-1 [22, 23] can be both chemotactic [24] and proapoptotic [15, 39] . The dual effect of MCP-1 on HUVEC may at least partially be explained by 'monocyte-endothelial cell interactions' [40] . The monolayer ECs contribute a lot to the integrity of endothelium where the apoptosis and turnover of ECs strike a balance under normal condition. When apoptotic rate of EC increases, for example, affected by MCP-1, such balance breaks and the precisely controlled permeability of intima increases. Sequentially, infiltration of monocytes and smooth muscle cells is increased, lipids are inhaled and deposited, plaques are formed, and ultimately the vasculature is damaged, such as atherosclerosis.
Recent studies showed that chemokines and their receptors were implicated in apoptosis. Hesselgesser et al. first discovered that human immunodeficiency virus (HIV-1) infected hNT neurons apoptosis when the virus envelope glycoprotein gp120 bound to its co-receptor CXCR4 instead of the other co-receptor CD4 [41] . Through the same chemokine receptor, gp120 induced CD8-positive T cells apoptosis [42] . The both effects could be verified by stromal-derived factor-1 (SDF-1), the physiological ligand of the chemokine receptor CXCR4 [41, 42] . Chemokines are also revealed to be involved in apoptosis. The CXC chemokine CXCL12 (SDF-1a) produced by melanoma cells is capable of upregulating CCL5 production and initiating tumor-infiltrating lymphocytes (TIL) cell death [43] . Neutralization of the chemokine CXCL10 with its antibody reduced neuron apoptosis after spinal cord injury [44] . Chemokines not only induce neuronal and immunological cells, but also other sorts of cells, death. We reported here the chemokine MCP-1-induced vascular cell apoptosis. Thus, the mechanisms of apoptosis regulated by chemokines are complicated.
It was thought that the induction of epithelial cell apoptosis might counteract angiogenesis [45] , and there indeed is some solid evidence [46, 47] . MCP-1 has been recognized as an established direct angiogenic factor [48, 49] . However, we demonstrated here that MCP-1 was proapoptotic to HUVECs in vitro. We proposed that maybe the cells themselves and the growth microenvironment account for the difference. We introduced the established HUVEC strain CRL-1730 (ATCC) in our study, while other investigators used primary cell isolated from neonatal umbilical cord that might be contaminated by other sorts of cells. Also the established cell strain may chance some biological changes beyond our recognition. Another possibility is that additives in the medium like vascular endothelial growth factor might contribute to angiogenesis by which MCP-1 apoptotic effect might be masked [49] . A novel zinc finger transcription factor MCP-1-induced protein (MCPIP) has been reported to act as a proapoptotic factor in other cell types when stimulated with MCP-1 [39, 50] . We found that this protein was immediate early expressed in MCP-1-treated HUVECs (unpublished data), but how this factor involves in MCP-1-induced apoptosis is expected to be figured out in future research.
In conclusion, our findings provide direct and clear evidence that MCP-1 facilitates HUVECs apoptosis in vitro via a p53-dependent mitochondrial pathway, which opens a new window for the vision of MCP-1 actions in the development of atherosclerosis.
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